With the emergence of the COVID-19 pandemic, we are all experiencing uncertainty. This uncertainty is impacting our personal lives, and it’s also impacting and reshaping the critical research biotech and specialty pharma companies are conducting.
In the first of a special new podcast series, hear from Nach Dave, Premier Research’s Vice President of Development Strategy, about how the pandemic is affecting clinical research and what sponsors need to know about the just-published FDA guidance.
Read Nach’s blog at premier-research.com/fda-guidance-clinical-trials-covid-19.
Find more resources at https://premier-research.com/perspectives-blog/.
Contact our COVID-19 Task Force at COVIDemail@example.com.